Insider Transactions in Q4 2021 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 08
2021
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+50.0%
|
$144,000
$48.11 P/Share
|
Nov 04
2021
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-64.15%
|
$804,000
$201.44 P/Share
|
Nov 04
2021
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+39.08%
|
$212,000
$53.83 P/Share
|
Nov 04
2021
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
3,083
-95.95%
|
$616,600
$200.0 P/Share
|
Nov 04
2021
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,083
+48.97%
|
$163,399
$53.42 P/Share
|
Nov 04
2021
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-4.92%
|
$1,206,000
$201.71 P/Share
|
Nov 04
2021
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.4%
|
$666,000
$111.0 P/Share
|
Nov 02
2021
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-64.15%
|
$768,000
$192.2 P/Share
|
Nov 02
2021
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+39.08%
|
$212,000
$53.83 P/Share
|
Oct 28
2021
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-64.15%
|
$768,000
$192.17 P/Share
|
Oct 28
2021
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+39.08%
|
$212,000
$53.83 P/Share
|
Oct 26
2021
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-64.15%
|
$760,000
$190.45 P/Share
|
Oct 26
2021
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+39.08%
|
$212,000
$53.83 P/Share
|
Oct 21
2021
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-64.15%
|
$760,000
$190.66 P/Share
|
Oct 21
2021
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+39.08%
|
$212,000
$53.83 P/Share
|
Oct 21
2021
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-7.35%
|
$1,140,000
$190.18 P/Share
|
Oct 21
2021
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.4%
|
$666,000
$111.0 P/Share
|
Oct 07
2021
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,000
-64.15%
|
$780,000
$195.94 P/Share
|
Oct 07
2021
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+39.08%
|
$212,000
$53.83 P/Share
|
Oct 07
2021
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-4.94%
|
$1,140,000
$190.86 P/Share
|
Oct 07
2021
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.4%
|
$666,000
$111.0 P/Share
|